SAYYID, R. K.; DINGAR, D.; FLESHNER, K.; THORBURN, T.; DIAMOND, J.; YAO, E.; HERSEY, K.; CHADWICK, K.; PERLIS, N.; KLOTZ, L.; FINELLI, A.; HAMILTON, R.; KULKARNI, G.; ZLOTTA, A.; FLESHNER, N. What false-negative rates of non-invasive testing are active surveillance patients and uro-oncologists willing to accept in order to avoid prostate biopsy?. Canadian Urological Association Journal, [S. l.], v. 11, n. 3-4, p. 118–22, 2017. DOI: 10.5489/cuaj.4182. Disponível em: https://cuaj.ca/index.php/journal/article/view/4182. Acesso em: 1 may. 2024.